Mural Oncology Plc
(MURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 115,462 | 270,852 | N/A |
| Marketable Securities | 28,923 | N/A | N/A |
| Receivables | 51 | 5,548 | N/A |
| Other current assets | 805 | 787 | 1,830 |
| TOTAL | $152,917 | $277,337 | $4,817 |
| Non-Current Assets | |||
| PPE Net | 7,715 | 11,403 | 10,617 |
| Other Non-Current Assets | 8,762 | 13,005 | 18,316 |
| TOTAL | $16,477 | $24,408 | $28,933 |
| Total Assets | $169,394 | $301,745 | $33,750 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,056 | 5,973 | 2,966 |
| Accrued Expenses | 18,534 | 16,946 | 32,750 |
| Other current liabilities | 45 | N/A | N/A |
| TOTAL | $26,195 | $29,017 | $41,560 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 2,697 | 8,911 | 13,846 |
| TOTAL | $2,697 | $8,911 | $13,846 |
| Total Liabilities | $28,892 | $37,928 | $55,406 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 17,228 | 16,923 | N/A |
| Common Shares | 171 | 167 | N/A |
| Retained earnings | -159,371 | -30,857 | N/A |
| Other shareholders' equity | 20 | 0 | -21,656 |
| TOTAL | $140,502 | $263,817 | $-21,656 |
| Total Liabilities And Equity | $169,394 | $301,745 | $33,750 |